Pharmaceutical trade group urges US Congress to oppose Inflation Reduction Act

Pharmaceutical Research and Manufacturers of America (PhRMA), a trade group representing the pharmaceutical industry in the United States, released a letter urging Congress to reject the Cut Inflation Act because its passage would lead to a reduction in inflation. access to innovative medicines.

The law would allow Medicare, a federal health insurance program for people age 65 or older and people with certain disabilities, to negotiate prescription drug prices and expand…

This article is accessible to registered users, to continue reading, please register for free. A free trial will give you access to exclusive features, interviews, summaries and commentary from the sharpest minds in the pharma and biotech space for one week. If you are already a registered user, please login. If your trial period is over, you can register here.

Try before you buy

• All the news that moves the needle in pharma and biotech.
• Exclusive features, podcasts, interviews, data analysis and commentary from our global network of life science journalists.
• Receive The Pharma Letter daily newsletter, free forever.

Become a subscriber

• Unfettered access to top pharmaceutical and biotechnology industry news, commentary and analysis.
• Updates on clinical trials, conferences, mergers and acquisitions, licensing, financing, regulatory, patent and legal, executive appointments, business strategy and financial results.
• Daily roundup of key events in pharma and biotechnology.
• In-depth monthly briefings on board appointments and M&A news.
• Choose between an economical annual plan or a flexible monthly subscription.

About Alexander Estrada

Check Also

Putin admits China has ‘questions and concerns’ over Russia’s failed invasion of Ukraine

hong kong CNN — Russian President Vladimir Putin on Thursday hailed China’s ‘balanced stance’ on …